Galecto GLTO Stock
Galecto Price Chart
Galecto GLTO Financial and Trading Overview
| Galecto stock price | 2.86 USD |
| Previous Close | 2.18 USD |
| Open | 2.2 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 2.18 - 2.26 USD |
| 52 Week Range | 1.04 - 2.95 USD |
| Volume | 7.4K USD |
| Avg. Volume | 65.87K USD |
| Market Cap | 57.77M USD |
| Beta (5Y Monthly) | 0.740658 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -18.53 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12 USD |
GLTO Valuation Measures
| Enterprise Value | 3.41M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.076555 |
| PEG Ratio (5 yr expected) | -0.02 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.1473738 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.059 |
Trading Information
Galecto Stock Price History
| Beta (5Y Monthly) | 0.740658 |
| 52-Week Change | 29.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.95 USD |
| 52 Week Low | 1.04 USD |
| 50-Day Moving Average | 2.1 USD |
| 200-Day Moving Average | 1.98 USD |
GLTO Share Statistics
| Avg. Volume (3 month) | 65.87K USD |
| Avg. Daily Volume (10-Days) | 33.31K USD |
| Shares Outstanding | 25.67M |
| Float | 17.62M |
| Short Ratio | 0.11 |
| % Held by Insiders | 0.40% |
| % Held by Institutions | 39.60% |
| Shares Short | 12.18K |
| Short % of Float | 0.069% |
| Short % of Shares Outstanding | 0.050% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -41.59% |
| Return on Equity (ttm) | -76.070% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -57708000 USD |
| Net Income Avi to Common (ttm) | -57680000 USD |
| Diluted EPS (ttm) | -2.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 53.25M USD |
| Total Cash Per Share (mrq) | 2.07 USD |
| Total Debt (mrq) | 686K USD |
| Total Debt/Equity (mrq) | 1.36 USD |
| Current Ratio (mrq) | 4.062 |
| Book Value Per Share (mrq) | 1.961 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -45269000 USD |
| Levered Free Cash Flow (ttm) | -23867000 USD |
Profile of Galecto
| Country | United States |
| State | N/A |
| City | Copenhagen |
| Address | Ole Maaloes Vej 3 |
| ZIP | 2200 |
| Phone | 45 70 70 52 10 |
| Website | https://galecto.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 45 |
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Q&A For Galecto Stock
What is a current GLTO stock price?
Galecto GLTO stock price today per share is 2.86 USD.
How to purchase Galecto stock?
You can buy GLTO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Galecto?
The stock symbol or ticker of Galecto is GLTO.
Which industry does the Galecto company belong to?
The Galecto industry is Biotechnology.
How many shares does Galecto have in circulation?
The max supply of Galecto shares is 1.32M.
What is Galecto Price to Earnings Ratio (PE Ratio)?
Galecto PE Ratio is now.
What was Galecto earnings per share over the trailing 12 months (TTM)?
Galecto EPS is -18.53 USD over the trailing 12 months.
Which sector does the Galecto company belong to?
The Galecto sector is Healthcare.
Galecto GLTO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
| NASDAQ Global Select Market Com NQGS | 8098.63 USD — |
-5.98
|
— — | 8089.65 USD — | 8265.47 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}